Sublingual Allergy Immunotherapy Market by Type and Application - Global Industry Analysis & Forecast to 2027
Published On : November 2019 Pages : 160 Category: Medical Devices Report Code : HC116892
Sublingual Allergy Immunotherapy Market by Type (Drop Form, Tablet Form) Application (Asthma, Rhinitis, Eczema, Other) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Sublingual Allergy Immunotherapy Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Sublingual Allergy Immunotherapy is a technique for treating sensitivities by giving a medication under the tongue. Expanding frequencies of allergies and inadequate treatment systems, for example, pharmacotherapy, for controlling the event pace of hypersensitivities are fuelling adoption of hypersensitivity immunotherapy, which is considered as an assigned remedy for different kinds of allergies.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Merck
- Stallergenes Greer
- Allergy Therapeutics
- ALK-Abello
- Hal-Allergy
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Sublingual Allergy Immunotherapy Market , By Type, Estimates and Forecast, 2017-2027 ($Million)
o Drop Form
o Tablet Form
· Sublingual Allergy Immunotherapy Market , By Application, Estimates and Forecast, 2017-2027 ($Million)
o Asthma
o Rhinitis
o Eczema
o Other
· Sublingual Allergy Immunotherapy Market , By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Merck
o Stallergenes Greer
o Allergy Therapeutics
o ALK-Abello
o Hal-Allergy
· Sublingual Allergy Immunotherapy Market , By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Sublingual Allergy Immunotherapy Market , By Country
o U.S. Sublingual Allergy Immunotherapy Market
o Canada Sublingual Allergy Immunotherapy Market
o Mexico Sublingual Allergy Immunotherapy Market
o Europe
§ Europe Sublingual Allergy Immunotherapy Market , By Country
· Germany Sublingual Allergy Immunotherapy Market
o UK Sublingual Allergy Immunotherapy Market
o France Sublingual Allergy Immunotherapy Market
o Russia Sublingual Allergy Immunotherapy Market
o Italy Sublingual Allergy Immunotherapy Market
o Rest of Europe Sublingual Allergy Immunotherapy Market
o Asia-Pacific
§ Asia-Pacific Sublingual Allergy Immunotherapy Market , By Country
o China Sublingual Allergy Immunotherapy Market
o Japan Sublingual Allergy Immunotherapy Market
o South Korea Sublingual Allergy Immunotherapy Market
o India Sublingual Allergy Immunotherapy Market
o Southeast Asia Sublingual Allergy Immunotherapy Market
o Rest of Asia-Pacific Sublingual Allergy Immunotherapy Market
o South America
§ South America Sublingual Allergy Immunotherapy Market
o Brazil Sublingual Allergy Immunotherapy Market
o Argentina Sublingual Allergy Immunotherapy Market
o Columbia Sublingual Allergy Immunotherapy Market
o Rest of South America Sublingual Allergy Immunotherapy Market
o Middle East and Africa
§ Middle East and Africa Sublingual Allergy Immunotherapy Market
o Saudi Arabia Sublingual Allergy Immunotherapy Market
o UAE Sublingual Allergy Immunotherapy Market
o Egypt Sublingual Allergy Immunotherapy Market
o Nigeria Sublingual Allergy Immunotherapy Market
o South Africa Sublingual Allergy Immunotherapy Market
o Rest of MEA Sublingual Allergy Immunotherapy Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Sublingual Allergy Immunotherapy Market, By Type
5.1. Introduction
5.2. Global Sublingual Allergy Immunotherapy Revenue and Market Share by Type (2017-2027)
5.2.1. Global Sublingual Allergy Immunotherapy Revenue and Revenue Share by Type (2017-2027)
5.3. Drop Form
5.3.1. Global Drop Form Revenue and Growth Rate (2017-2027)
5.4. Tablet Form
5.4.1. Global Tablet Form Revenue and Growth Rate (2017-2027)
6. Sublingual Allergy Immunotherapy Market, By Application
6.1. Introduction
6.2. Global Sublingual Allergy Immunotherapy Revenue and Market Share by Application (2017-2027)
6.2.1. Global Sublingual Allergy Immunotherapy Revenue and Revenue Share by Application (2017-2027)
6.3. Asthma
6.3.1. Global Asthma Revenue and Growth Rate (2017-2027)
6.4. Rhinitis
6.4.1. Global Rhinitis Revenue and Growth Rate (2017-2027)
6.5. Eczema
6.5.1. Global Eczema Revenue and Growth Rate (2017-2027)
6.6. Other
6.6.1. Global Other Revenue and Growth Rate (2017-2027)
7. Sublingual Allergy Immunotherapy Market, By Region
7.1. Introduction
7.2. Global Sublingual Allergy Immunotherapy Revenue and Market Share by Regions
7.2.1. Global Sublingual Allergy Immunotherapy Revenue by Regions (2017-2027)
7.3. North America Sublingual Allergy Immunotherapy by Countries
7.3.1. North America Sublingual Allergy Immunotherapy Revenue and Growth Rate (2017-2027)
7.3.2. North America Sublingual Allergy Immunotherapy Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Sublingual Allergy Immunotherapy by Countries
7.4.1. Europe Sublingual Allergy Immunotherapy Revenue and Growth Rate (2017-2027)
7.4.2. Europe Sublingual Allergy Immunotherapy Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Sublingual Allergy Immunotherapy by Countries
7.5.1. Asia-Pacific Sublingual Allergy Immunotherapy Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Sublingual Allergy Immunotherapy Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Sublingual Allergy Immunotherapy by Countries
7.6.1. South America Sublingual Allergy Immunotherapy Revenue and Growth Rate (2017-2027)
7.6.2. South America Sublingual Allergy Immunotherapy Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Sublingual Allergy Immunotherapy by Countries
7.7.1. Middle East and Africa Sublingual Allergy Immunotherapy Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Sublingual Allergy Immunotherapy Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Merck
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Stallergenes Greer
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Allergy Therapeutics
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. ALK-Abello
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Hal-Allergy
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
9. Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.1. Global Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Sublingual Allergy Immunotherapy Market Forecast by Regions (2017-2027)
9.2.1. North America Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.1.1. United States Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.1.2. Canada Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.1.3. Mexico Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.2. Europe Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.2.1. Germany Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.2.2. France Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.2.3. UK Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.2.4. Russia Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.2.5. Italy Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.3. Asia-Pacific Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.3.1. China Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.3.2. Japan Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.3.3. Korea Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.3.4. India Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.4. South America Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.4.1. Brazil Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.4.2. Argentina Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.4.3. Columbia Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.4.4. Rest of South America Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.5. Middle East and Africa Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.5.3. Egypt Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.5.4. Nigeria Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.5.5. South Africa Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.5.6. Turkey Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Sublingual Allergy Immunotherapy Market Forecast (2017-2027)
9.3. Sublingual Allergy Immunotherapy Market Forecast by Type (2017-2027)
9.3.1. Sublingual Allergy Immunotherapy Forecast by Type (2017-2027)
9.3.2. Sublingual Allergy Immunotherapy Market Share Forecast by Type (2017-2027)
9.4. Sublingual Allergy Immunotherapy Market Forecast by Application (2017-2027)
9.4.1. Sublingual Allergy Immunotherapy Forecast by Application (2017-2027)
9.4.2. Sublingual Allergy Immunotherapy Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Sublingual Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Sublingual Allergy Immunotherapy Revenue and Revenue Share by Type (2017-2018)
Figure Global Drop Form Revenue and Growth Rate (2017-2018)
Figure Global Tablet Form Revenue and Growth Rate (2017-2018)
Table Global Sublingual Allergy Immunotherapy Revenue and Revenue Share by Application (2017-2018)
Figure Global Asthma Revenue and Growth Rate (2017-2018)
Figure Global Rhinitis Revenue and Growth Rate (2017-2018)
Figure Global Eczema Revenue and Growth Rate (2017-2018)
Figure Global Other Revenue and Growth Rate (2017-2018)
Table Global Sublingual Allergy Immunotherapy Revenue by Regions (2017-2018)
Figure North America Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure North America Sublingual Allergy Immunotherapy Revenue and Growth Rate (2017-2018)
Figure North America Sublingual Allergy Immunotherapy by Countries (2017-2018)
Figure North America Sublingual Allergy Immunotherapy Revenue (Million USD) by Countries (2017-2018)
Figure United States Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure United States Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure Canada Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure Mexico Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure Europe Sublingual Allergy Immunotherapy Revenue and Growth Rate (2017-2018)
Figure Europe Sublingual Allergy Immunotherapy by Countries (2017-2018)
Figure Europe Sublingual Allergy Immunotherapy Revenue (Million USD) by Countries (2017-2018)
Figure Germany Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure Germany Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure France Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure UK Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure Russia Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure Italy Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure Rest of Europe Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure Asia-Pacific Sublingual Allergy Immunotherapy Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Sublingual Allergy Immunotherapy by Countries (2017-2018)
Figure Asia-Pacific Sublingual Allergy Immunotherapy Revenue (Million USD) by Countries (2017-2018)
Figure China Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure China Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure Japan Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure Korea Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure India Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure Southeast Asia Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure South America Sublingual Allergy Immunotherapy Revenue and Growth Rate (2017-2018)
Figure South America Sublingual Allergy Immunotherapy by Countries (2017-2018)
Figure South America Sublingual Allergy Immunotherapy Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure Brazil Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure Argentina Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure Columbia Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure Rest of South America Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure Middle East and Africa Sublingual Allergy Immunotherapy Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Sublingual Allergy Immunotherapy by Countries (2017-2018)
Figure Middle East and Africa Sublingual Allergy Immunotherapy Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure Saudi Arabia Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure United Arab Emirates Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure Egypt Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure Nigeria Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure South Africa Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure Turkey Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Sublingual Allergy Immunotherapy Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2017-2018)
Table Merck Sublingual Allergy Immunotherapy Financial Overview
Table Stallergenes Greer Sublingual Allergy Immunotherapy Financial Overview
Table Allergy Therapeutics Sublingual Allergy Immunotherapy Financial Overview
Table ALK-Abello Sublingual Allergy Immunotherapy Financial Overview
Table Hal-Allergy Sublingual Allergy Immunotherapy Financial Overview
Figure Global Sublingual Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2018-2025)
Table Sublingual Allergy Immunotherapy Market Forecast by Regions (2018-2025)
Figure North America Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure United States Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure Canada Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure Mexico Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure Europe Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure Germany Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure France Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure UK Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure Russia Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure Italy Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure Rest of Europe Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure Asia-Pacific Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure China Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure Japan Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure Korea Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure India Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure Southeast Asia Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure South America Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure Brazil Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure Argentina Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure Columbia Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure Rest of South America Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure Middle East and Africa Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure Saudi Arabia Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure United Arab Emirates Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure Egypt Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure Nigeria Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure South Africa Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure Turkey Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Sublingual Allergy Immunotherapy Market Forecast (2018-2025)
Figure Global Sublingual Allergy Immunotherapy Forecast by Type (2018-2025)
Figure Global Sublingual Allergy Immunotherapy Market Share Forecast by Type (2018-2025)
Figure Global Sublingual Allergy Immunotherapy Forecast by Type (2018-2025)
Figure Global Sublingual Allergy Immunotherapy Forecast by Application (2018-2025)
Figure Global Sublingual Allergy Immunotherapy Market Share Forecast by Application (2018-2025)
Figure Global Sublingual Allergy Immunotherapy Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|